The emerging role of prostate-specific membrane antigen–targeted radioligand therapy in metastatic hormone-sensitive prostate cancer

Philipose Mulugeta, Tanya Dorff, Jason Hafron, Mai Anh Huynh, Alicia K Morgans, Ashley E Ross, Rana R McKay

Open source

DOI: 10.1093/oncolo/oyag173
Published: 2026-05-11
Container: The Oncologist
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/oncolo/oyag173,
  title = {The emerging role of prostate-specific membrane antigen–targeted radioligand therapy in metastatic hormone-sensitive prostate cancer},
  author = {Philipose Mulugeta and Tanya Dorff and Jason Hafron and Mai Anh Huynh and Alicia K Morgans and Ashley E Ross and Rana R McKay},
  year = {2026},
  journal = {The Oncologist},
  doi = {10.1093/oncolo/oyag173},
  url = {https://doi.org/10.1093/oncolo/oyag173}
}

RIS

TY  - JOUR
TI  - The emerging role of prostate-specific membrane antigen–targeted radioligand therapy in metastatic hormone-sensitive prostate cancer
AU  - Philipose Mulugeta
AU  - Tanya Dorff
AU  - Jason Hafron
AU  - Mai Anh Huynh
AU  - Alicia K Morgans
AU  - Ashley E Ross
AU  - Rana R McKay
PY  - 2026
JO  - The Oncologist
DO  - 10.1093/oncolo/oyag173
UR  - https://doi.org/10.1093/oncolo/oyag173
ER  -

APA

Mulugeta, P., Dorff, T., Hafron, J., Huynh, M. A., Morgans, A. K., Ross, A. E., & McKay, R. R. (2026). The emerging role of prostate-specific membrane antigen–targeted radioligand therapy in metastatic hormone-sensitive prostate cancer. The Oncologist. https://doi.org/10.1093/oncolo/oyag173

Source records

crossref · retrieved 2026-09-26T21:40:39.095Z